These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 35756491)
1. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. Chen Y Dis Markers; 2022; 2022():6410113. PubMed ID: 35756491 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment. Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792 [TBL] [Abstract][Full Text] [Related]
3. Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach. Gong X; Ren F Dis Markers; 2022; 2022():5239033. PubMed ID: 35711568 [TBL] [Abstract][Full Text] [Related]
4. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma. Liu S; Wang Z Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436 [TBL] [Abstract][Full Text] [Related]
5. Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis. Huang C; Liu J Genet Res (Camb); 2022; 2022():6880760. PubMed ID: 36636556 [TBL] [Abstract][Full Text] [Related]
6. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Huang J; Liang B; Wang T Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372 [TBL] [Abstract][Full Text] [Related]
7. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571 [TBL] [Abstract][Full Text] [Related]
8. DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma. Li R; Wen X; Lv RX; Ren XY; Cheng BL; Wang YK; Chen RZ; Hu W; Tang XR Cell Oncol (Dordr); 2024 Aug; 47(4):1129-1148. PubMed ID: 38315286 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy. Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504 [TBL] [Abstract][Full Text] [Related]
10. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Li Y; Liu H Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446 [TBL] [Abstract][Full Text] [Related]
11. Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma. Liu S; Wang S; Wang Z BMC Med Genomics; 2023 May; 16(1):110. PubMed ID: 37210507 [TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma. Hu R; Lu M; She L Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444 [TBL] [Abstract][Full Text] [Related]
13. PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma. Wang L; Chen K; Weng S; Xu H; Ren Y; Cheng Q; Luo P; Zhang J; Liu Z; Han X World J Surg Oncol; 2023 Mar; 21(1):72. PubMed ID: 36864522 [TBL] [Abstract][Full Text] [Related]
14. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
15. FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma. Liang H; Zhang C; Li C; Li C; Wang Y; Lin H Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34028536 [TBL] [Abstract][Full Text] [Related]
16. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ Front Immunol; 2022; 13():975847. PubMed ID: 36091055 [TBL] [Abstract][Full Text] [Related]
17. Dai Y; Chen W; Huang J; Cui T Biomed Res Int; 2021; 2021():8874578. PubMed ID: 34285919 [TBL] [Abstract][Full Text] [Related]
18. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment. Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor. Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma. Miao Y; Chen Q; Liu X; Bu J; Zhang Z; Liu T; Yue Z; Huang L; Sun S; Li H; Yang A; Yang Z; Chen C Sci Rep; 2024 Jul; 14(1):16972. PubMed ID: 39043683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]